Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Clinical trial NCT05658575 · RECRUITING

Trial details

NCT number: NCT05658575
Sponsor: Olatec Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Gout Flare Gout Attack Gout Flare Gouty Arthritis Gout Arthritis Joint Pain

Start date: 2023-01-06
Primary completion: 2026-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.